Solbritt Rantapää-Dahlqvist

researcher

Solbritt Rantapää-Dahlqvist is …
instance of (P31):
humanQ5

P106occupationresearcherQ1650915
P21sex or genderfemaleQ6581072

Reverse relations

author (P50)
Q28258975A STAT4 risk allele is associated with ischaemic cerebrovascular events and anti-phospholipid antibodies in systemic lupus erythematosus
Q34694711A candidate gene study of the type I interferon pathway implicates IKBKE and IL8 as risk loci for SLE.
Q24629130A large-scale replication study identifies TNIP1, PRDM1, JAZF1, UHRF1BP1 and IL10 as risk loci for systemic lupus erythematosus
Q36851638A risk haplotype of STAT4 for systemic lupus erythematosus is over-expressed, correlates with anti-dsDNA and shows additive effects with two risk alleles of IRF5.
Q37450136Abdominal obesity, gender and the risk of rheumatoid arthritis - a nested case-control study
Q35620298Antibodies of IgG, IgA and IgM isotypes against cyclic citrullinated peptide precede the development of rheumatoid arthritis
Q36475075Association analysis of copy numbers of FC-gamma receptor genes for rheumatoid arthritis and other immune-mediated phenotypes
Q35092932Association between the PTPN22 +1858 C/T polymorphism and psoriatic arthritis
Q28254474Association of a PDCD1 polymorphism with renal manifestations in systemic lupus erythematosus
Q28265206Association of systemic lupus erythematosus with C8orf13-BLK and ITGAM-ITGAX
Q35626851Associations of antibodies against citrullinated peptides with human leukocyte antigen-shared epitope and smoking prior to the development of rheumatoid arthritis
Q34153114Atherosclerosis in early rheumatoid arthritis: very early endothelial activation and rapid progression of intima media thickness
Q35620360Autoantibodies predate the onset of systemic lupus erythematosus in northern Sweden
Q35617716Cardiovascular events in early RA are a result of inflammatory burden and traditional risk factors: a five year prospective study
Q33859039Cardiovascular risk factors predate the onset of symptoms of rheumatoid arthritis: a nested case-control study
Q36513993Co-morbidity in patients with early rheumatoid arthritis - inflammation matters
Q37240538Concentration of antibodies against Porphyromonas gingivalis is increased before the onset of symptoms of rheumatoid arthritis
Q28290376Coronary heart disease in systemic lupus erythematosus is associated with interferon regulatory factor-8 gene variants
Q35620317Diagnostic properties of metabolic perturbations in rheumatoid arthritis
Q40131399Direct and indirect costs for systemic lupus erythematosus in Sweden. A nationwide health economic study based on five defined cohorts
Q39043111EULAR definition of arthralgia suspicious for progression to rheumatoid arthritis
Q39875697Epitope spreading of the anti-citrullinated protein antibody response occurs before disease onset and is associated with the disease course of early arthritis
Q37102098Genes identified in Asian SLE GWASs are also associated with SLE in Caucasian populations
Q41583910Genetic Variants of the NLRP3 Inflammasome Are Associated with Stroke in Patients with Rheumatoid Arthritis
Q29417000Genetics of rheumatoid arthritis contributes to biology and drug discovery
Q30419111High-density genetic mapping identifies new susceptibility loci for rheumatoid arthritis
Q36307076Influence of FCGR3A genotype on the therapeutic response to rituximab in rheumatoid arthritis: an observational cohort study
Q36172927Is Lipoprotein-Associated Phospholipase A2 a Link between Inflammation and Subclinical Atherosclerosis in Rheumatoid Arthritis?
Q24816519Levels of gastrin-releasing peptide and substance P in synovial fluid and serum correlate with levels of cytokines in rheumatoid arthritis.
Q35094654Measurements in the Blood of BDNF for RA Patients and in Response to Anti-TNF Treatment Help Us to Clarify the Magnitude of Centrally Related Pain and to Explain the Relief of This Pain upon Treatment
Q36166090Metabolite and Lipid Profiling of Biobank Plasma Samples Collected Prior to Onset of Rheumatoid Arthritis
Q35128863Novel information on the non-neuronal cholinergic system in orthopedics provides new possible treatment strategies for inflammatory and degenerative diseases
Q34896568PTPN22 polymorphism and anti-cyclic citrullinated peptide antibodies in combination strongly predicts future onset of rheumatoid arthritis and has a specificity of 100% for the disease
Q24530690Polymorphisms in the tyrosine kinase 2 and interferon regulatory factor 5 genes are associated with systemic lupus erythematosus
Q40850003Response to biological treatment and subsequent risk of coronary events in rheumatoid arthritis
Q36565997Rheumatoid factor isotypes in relation to antibodies against citrullinated peptides and carbamylated proteins before the onset of rheumatoid arthritis
Q35876782Selective IgA deficiency in autoimmune diseases
Q35990362Studies on ageing and the severity of radiographic joint damage in rheumatoid arthritis
Q33749195Ten years with biologics: to whom do data on effectiveness and safety apply?
Q36392280The PTPN22 1858C/T polymorphism is associated with anti-cyclic citrullinated peptide antibody-positive early rheumatoid arthritis in northern Sweden
Q33892790The risk of acute coronary syndrome in rheumatoid arthritis in relation to tumour necrosis factor inhibitors and the risk in the general population: a national cohort study
Q36013844Time-dependent increase in risk of hospitalisation with infection among Swedish RA patients treated with TNF antagonists
Q37443729What happens before the onset of rheumatoid arthritis?
Q30278872Widespread non-additive and interaction effects within HLA loci modulate the risk of autoimmune diseases

Search more.